Delaware (State or other jurisdiction of incorporation) |
000-06920 (Commission File Number) |
94-1655526 (IRS Employer Identification No.) |
3050 Bowers Avenue | ||
P.O. Box 58039 | ||
Santa Clara, CA | 95052-8039 | |
(Address of principal | (Zip Code) | |
executive offices) |
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition. | ||||||||
Item 9.01 Financial Statements and Exhibits. | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
EXHIBIT 99.1 |
Exhibit No. | Description | |
99.1
|
Press Release issued by Applied Materials, Inc. dated November 14, 2007. |
Applied Materials, Inc. (Registrant) |
||||
Date: November 14, 2007 | By: | /s/ Joseph J. Sweeney | ||
Joseph J. Sweeney | ||||
Senior Vice President, General Counsel and Corporate Secretary |
||||
Exhibit No. | Description | |
99.1
|
Press Release issued by Applied Materials, Inc. dated November 14, 2007. |
Operating | ||||||||||||
(In millions) | New Orders | Net Sales | Income (loss) | |||||||||
Silicon |
$ | 6,651 | $ | 6,512 | $ | 2,379 | ||||||
Fab Solutions |
$ | 2,374 | $ | 2,196 | $ | 572 | ||||||
Display |
$ | 407 | $ | 862 | $ | 217 | ||||||
Adjacent Technologies |
$ | 245 | $ | 165 | $ | (89 | ) |
Operating | ||||||||||||
(In millions) | New Orders | Net Sales | Income (loss) | |||||||||
Silicon |
$ | 1,343 | $ | 1,511 | $ | 550 | ||||||
Fab Solutions |
$ | 602 | $ | 572 | $ | 148 | ||||||
Display |
$ | 163 | $ | 222 | $ | 58 | ||||||
Adjacent Technologies |
$ | 98 | $ | 62 | $ | (30 | ) |
Three Months Ended | Twelve Months Ended | |||||||||||||||
October 29, | October 28, | October 29, | October 28, | |||||||||||||
(In thousands, except per share amounts) | 2006 | 2007 | 2006 | 2007 | ||||||||||||
Net sales |
$ | 2,518,293 | $ | 2,367,044 | $ | 9,167,014 | $ | 9,734,856 | ||||||||
Cost of products sold |
1,332,169 | 1,290,139 | 4,875,212 | 5,242,413 | ||||||||||||
Gross margin |
1,186,124 | 1,076,905 | 4,291,802 | 4,492,443 | ||||||||||||
Operating expenses: |
||||||||||||||||
Research, development and engineering |
299,240 | 270,878 | 1,152,326 | 1,142,073 | ||||||||||||
Marketing and selling |
116,365 | 116,270 | 438,654 | 451,258 | ||||||||||||
General and administrative |
134,199 | 125,624 | 468,088 | 501,185 | ||||||||||||
Restructuring and asset impairments |
1,490 | 3,039 | 212,113 | 26,421 | ||||||||||||
Income from operations |
634,830 | 561,094 | 2,020,621 | 2,371,506 | ||||||||||||
Pre-tax loss of equity method investment |
2,849 | 12,162 | 2,849 | 29,371 | ||||||||||||
Interest expense |
9,308 | 9,243 | 36,096 | 38,631 | ||||||||||||
Interest income |
37,396 | 39,556 | 185,295 | 136,149 | ||||||||||||
Income before income taxes |
660,069 | 579,245 | 2,166,971 | 2,439,653 | ||||||||||||
Provision for income taxes |
211,040 | 157,484 | 650,308 | 729,457 | ||||||||||||
Net income |
$ | 449,029 | $ | 421,761 | $ | 1,516,663 | $ | 1,710,196 | ||||||||
Earnings per share: |
||||||||||||||||
Basic |
$ | 0.31 | $ | 0.31 | $ | 0.98 | $ | 1.22 | ||||||||
Diluted |
$ | 0.30 | $ | 0.30 | $ | 0.97 | $ | 1.20 | ||||||||
Weighted average number of shares: |
||||||||||||||||
Basic |
1,469,975 | 1,381,871 | 1,551,339 | 1,406,685 | ||||||||||||
Diluted |
1,482,132 | 1,403,687 | 1,565,072 | 1,427,002 | ||||||||||||
October 29, | October 28, | |||||||
(In thousands) | 2006 | 2007 | ||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 861,463 | $ | 1,202,722 | ||||
Short-term investments |
1,035,875 | 1,166,857 | ||||||
Accounts receivable, net |
2,026,199 | 2,049,427 | ||||||
Inventories |
1,406,777 | 1,313,237 | ||||||
Deferred income taxes |
455,473 | 424,502 | ||||||
Assets held for sale |
37,211 | | ||||||
Other current assets |
258,021 | 448,879 | ||||||
Total current assets |
6,081,019 | 6,605,624 | ||||||
Long-term investments |
1,314,861 | 1,362,425 | ||||||
Property, plant and equipment |
2,753,883 | 2,782,204 | ||||||
Less: accumulated depreciation and amortization |
(1,729,589 | ) | (1,730,962 | ) | ||||
Net property, plant and equipment |
1,024,294 | 1,051,242 | ||||||
Goodwill, net |
572,558 | 1,000,176 | ||||||
Purchased technology and other intangible assets, net |
201,066 | 373,178 | ||||||
Equity method investment |
144,431 | 115,060 | ||||||
Deferred income taxes and other assets |
142,608 | 146,370 | ||||||
Total assets |
$ | 9,480,837 | $ | 10,654,075 | ||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||
Current liabilities: |
||||||||
Current portion of long-term debt |
$ | 202,535 | $ | 2,561 | ||||
Accounts payable and accrued expenses |
2,023,651 | 2,213,313 | ||||||
Income taxes payable |
209,859 | 157,549 | ||||||
Total current liabilities |
2,436,045 | 2,373,423 | ||||||
Long-term debt |
204,708 | 202,281 | ||||||
Other liabilities |
188,684 | 256,962 | ||||||
Total liabilities |
2,829,437 | 2,832,666 | ||||||
Stockholders equity: |
||||||||
Common stock |
13,917 | 13,857 | ||||||
Additional paid-in capital |
3,678,202 | 4,658,832 | ||||||
Retained earnings |
9,472,303 | 10,863,291 | ||||||
Treasury stock |
(6,494,012 | ) | (7,725,924 | ) | ||||
Accumulated other comprehensive income (loss) |
(19,010 | ) | 11,353 | |||||
Total stockholders equity |
6,651,400 | 7,821,409 | ||||||
Total liabilities and stockholders equity |
$ | 9,480,837 | $ | 10,654,075 | ||||
Three Months Ended | Twelve Months Ended | |||||||||||||||||||
October 29, | July 29, | October 28, | October 29, | October 28, | ||||||||||||||||
(In thousands, except per share amounts) | 2006 | 2007 | 2007 | 2006 | 2007 | |||||||||||||||
Non-GAAP Net Income |
||||||||||||||||||||
Reported net income (GAAP basis) |
$ | 449,029 | $ | 473,515 | $ | 421,761 | $ | 1,516,663 | $ | 1,710,196 | ||||||||||
Equity-based compensation expense |
55,553 | 47,485 | 30,889 | 216,269 | 161,196 | |||||||||||||||
Restructuring and asset impairments 1, 2 |
1,490 | 1,616 | 3,039 | 212,113 | 26,421 | |||||||||||||||
Costs associated with ceasing development of
beamline implant products 3 |
| 6,373 | 9,391 | | 66,063 | |||||||||||||||
Certain items associated with acquisitions 4 |
18,456 | 18,911 | 29,497 | 49,157 | 85,513 | |||||||||||||||
Resolution of audits of prior years income
tax filings and changes in tax credits5 |
(20,000 | ) | (6,379 | ) | | (53,915 | ) | (36,242 | ) | |||||||||||
Income tax effect of non-GAAP adjustments |
(22,268 | ) | (23,137 | ) | (22,691 | ) | (142,712 | ) | (108,501 | ) | ||||||||||
Non-GAAP net income |
$ | 482,260 | $ | 518,384 | $ | 471,886 | $ | 1,797,575 | $ | 1,904,646 | ||||||||||
Non-GAAP Net Income Per Diluted Share |
||||||||||||||||||||
Reported net income per diluted share
(GAAP basis) |
$ | 0.30 | $ | 0.34 | $ | 0.30 | $ | 0.97 | $ | 1.20 | ||||||||||
Equity-based compensation expense |
0.03 | 0.02 | 0.02 | 0.11 | 0.08 | |||||||||||||||
Restructuring and asset impairments |
| | | 0.08 | 0.01 | |||||||||||||||
Costs associated with ceasing development
of beamline implant products |
| | | | 0.03 | |||||||||||||||
Certain items associated with acquisitions |
0.01 | 0.01 | 0.01 | 0.02 | 0.04 | |||||||||||||||
Resolution of audits of prior years income
tax filings and changes in tax credits |
(0.01 | ) | | | (0.03 | ) | (0.03 | ) | ||||||||||||
Non-GAAP net income per diluted share |
$ | 0.33 | $ | 0.37 | $ | 0.34 | $ | 1.15 | $ | 1.33 | ||||||||||
Shares used in diluted shares calculation |
1,482,132 | 1,407,264 | 1,403,687 | 1,565,072 | 1,427,002 | |||||||||||||||
1 | Results for the twelve months ended October 29, 2006 included asset impairment and restructuring charges of $212 million associated primarily with the facilities disinvestment program commenced in the first quarter of fiscal 2006. Results for the twelve months ended October 28, 2007 included adjustments from the sale of properties in Chunan, Korea, Hillsboro, Oregon and Narita, Japan. | |
2 | Results for the three and twelve months ended October 28, 2007 included restructuring and asset impairment charges of $3 million and $30 million, respectively, associated with ceasing development of beamline implant products. | |
3 | Results for the three and twelve months ended October 28, 2007 included other operating charges of $9 million and $66 million, respectively, associated with ceasing development of beamline implant products. | |
4 | Incremental charges attributable to acquisitions consisted of inventory fair value adjustments on products sold and amortization and impairment of purchased intangible assets. Results for the twelve months ended October 29, 2006 included an in-process research and development charge of $14 million associated with the acquisition of Applied Films Corporation in the third quarter of fiscal 2006. Results for the twelve months ended October 28, 2007 included an in-process research and development charge of $5 million associated with the acquisition of the software division of Brooks Automation, Inc. in the second fiscal quarter of 2007. | |
5 | Results for the twelve months ended October 29, 2006 included a $34 million benefit from the resolution of 2005 income tax filings. Results for the twelve months ended October 28, 2007 consisted of a $36 million benefit from the resolution of audits of prior years income tax filings and changes in tax credits. |